Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Scientists map neural pathways that lead to vomiting after eating contaminated food

Scientists map neural pathways that lead to vomiting after eating contaminated food

Investigating the role of the gut-to-brain axis in defensive responses

Investigating the role of the gut-to-brain axis in defensive responses

Molecular drug transporters could improve treatment of cancers and other diseases

Molecular drug transporters could improve treatment of cancers and other diseases

Penn State researchers lay the foundation for precision fabrication of tumor models

Penn State researchers lay the foundation for precision fabrication of tumor models

Novel drug target for triple-negative breast cancer discovered

Novel drug target for triple-negative breast cancer discovered

Did the diagnosis and management of Hodgkin lymphoma differ during the SARS-CoV-2 pandemic?

Did the diagnosis and management of Hodgkin lymphoma differ during the SARS-CoV-2 pandemic?

Exploring remdesivir resistance in COVID-19-infected transplant recipients

Exploring remdesivir resistance in COVID-19-infected transplant recipients

Study estimates the cost-effectiveness of therapeutic alternatives

Study estimates the cost-effectiveness of therapeutic alternatives

New advice aims to reduce the cardiac side effects of cancer treatment

New advice aims to reduce the cardiac side effects of cancer treatment

Best available chemotherapy for HIV-related Kaposi sarcoma would save lives and be cost-effective in Africa

Best available chemotherapy for HIV-related Kaposi sarcoma would save lives and be cost-effective in Africa

Biochemist finds new way to protect healthy leukocytes during chemotherapy

Biochemist finds new way to protect healthy leukocytes during chemotherapy

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Novel plug-and-play multi-organ chip can be customized to the patient

Novel plug-and-play multi-organ chip can be customized to the patient

Researchers develop novel device to “cleanse” the blood of chemotherapeutic drugs

Researchers develop novel device to “cleanse” the blood of chemotherapeutic drugs

Vitamin C may help to counteract common side effect of the chemotherapy drug

Vitamin C may help to counteract common side effect of the chemotherapy drug

Lower, more frequent doses of nanomedicines may provide additional benefits for cancer patients

Lower, more frequent doses of nanomedicines may provide additional benefits for cancer patients

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Scientists assemble carbon nanotubes in a new way to deliver cancer drugs

Scientists assemble carbon nanotubes in a new way to deliver cancer drugs

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs